Vaccines against Drugs
Drug addiction is a persistently recurring brain disorder.There is an essential need for new treatment options for this disease because the recurring rate among drug abusers is quite high. On the basis of preclinical work, vaccines for cocaine, tobacco, heroin and nicotine are now in clinical trials because they can offer long-term protection with basic treatment.
- 6-succinylmorphine (6-SM)
- Bovine serum albumin (BSA)
- Anticocaine vaccine
- Cocaine diamidehapten
Related Conference of Vaccines against Drugs
July 24-25, 2025
20th International Conference on Allergic Diseases and Clinical Immunology
Paris, France
August 26-27, 2025
6th International conference on Vaccines, Vaccination and Immunization
Paris, France
September 22-23, 2025
6th World Congress on Neuroimmunology and Neuroinfectious Diseases
Amsterdam, Netherlands
Vaccines against Drugs Conference Speakers
Recommended Sessions
- Adaptive Immunity
- Advances in Immunology Tests
- Cancer and Childhood Vaccines
- DNA Vaccines
- Geriatric Immunization
- How deadly is Corona Virus
- HPV and RV Vaccines
- Human Vaccines-Infectious and Non- Infectious
- Immune Response to Viral Infection
- Immunizable Diseases and their Vaccines
- Immunology and Pathology
- Immunoresearch and Immunotechnology
- Next-Generation Vaccine Delivery Technologies
- Plant- Based Vaccines
- Society and Cultural aspects of Vaccine
- Travel Immunization
- Vaccination and Immunization
- Vaccination for Pregnant Women
- Vaccine Regulatory Issues
- Vaccines against Drugs
Related Journals
Are you interested in
- Advances in Immunotherapy for Neuroimmune Disorders - Neuroimmunology Congress 2025 (Netherlands)
- Animal Models & Clinical Trials - Vaccines-Immunization-2025 (France)
- Antibodies: Engineering & Therapeutics - Vaccines-Immunization-2025 (France)
- Artificial Intelligence in Neuroimmunology Research - Neuroimmunology Congress 2025 (Netherlands)
- Autoimmunity in Neurodegenerative Diseases - Neuroimmunology Congress 2025 (Netherlands)
- Cancer Immunology and Immunotherapy - European Immunology 2025 (France)
- Cancer, Malaria & TB Vaccines - Vaccines-Immunization-2025 (France)
- Cellular and Molecular Immunotherapy in Neuroinfectious Diseases - Neuroimmunology Congress 2025 (Netherlands)
- Cellular Immunology & Latest Innovations - Vaccines-Immunization-2025 (France)
- Combination & Conjugate Vaccines - Vaccines-Immunization-2025 (France)
- Current Research & Future Challenges - Vaccines-Immunization-2025 (France)
- Diagnostic and Technological Novelty of Immunology - European Immunology 2025 (France)
- DNA & Synthetic Vaccines - Vaccines-Immunization-2025 (France)
- Emerging Viral Neuroinfections - Neuroimmunology Congress 2025 (Netherlands)
- Epidemiology - European Immunology 2025 (France)
- Fish & Poultry Vaccines - Vaccines-Immunization-2025 (France)
- Gene Editing and Neuroimmune Disorders - Neuroimmunology Congress 2025 (Netherlands)
- Genomics and Precision Medicine in Neuroimmunology - Neuroimmunology Congress 2025 (Netherlands)
- Geriatric Immunization - Vaccines-Immunization-2025 (France)
- HIV Vaccines - Vaccines-Immunization-2025 (France)
- Immune System - European Immunology 2025 (France)
- Immunodeficiency - European Immunology 2025 (France)
- Immunogenetics - European Immunology 2025 (France)
- Immunoinformatics & Systems Immunology - European Immunology 2025 (France)
- Immunological Techniques - European Immunology 2025 (France)
- Immunology - European Immunology 2025 (France)
- Immunometabolism in Neuroinflammation - Neuroimmunology Congress 2025 (Netherlands)
- Immunotherapy - European Immunology 2025 (France)
- Immunotoxicology - European Immunology 2025 (France)
- Innate Immunity in Neurological Diseases - Neuroimmunology Congress 2025 (Netherlands)
- Molecular Pathways in Neuroimmune Disorders - Neuroimmunology Congress 2025 (Netherlands)
- Neuroimmune Biomarkers: From Discovery to Clinical Application - Neuroimmunology Congress 2025 (Netherlands)
- Neuroimmune Mechanisms in CNS Infections - Neuroimmunology Congress 2025 (Netherlands)
- Neuroimmune Responses to Environmental Triggers - Neuroimmunology Congress 2025 (Netherlands)
- Neuroimmunology - European Immunology 2025 (France)
- Neuroimmunology of Aging and Neurodegeneration - Neuroimmunology Congress 2025 (Netherlands)
- Neuroimmunology of Pain and Neuropathic Conditions - Neuroimmunology Congress 2025 (Netherlands)
- Neuroinfectious Disease Epidemiology - Neuroimmunology Congress 2025 (Netherlands)
- Neuroinflammation and Psychiatric Disorders - Neuroimmunology Congress 2025 (Netherlands)
- Parasite Immunology - European Immunology 2025 (France)
- Peadiatric Vaccination - Vaccines-Immunization-2025 (France)
- Pediatrics Immunology - European Immunology 2025 (France)
- Reproductive Immunology - European Immunology 2025 (France)
- Role of Microglia in Neuroimmunology - Neuroimmunology Congress 2025 (Netherlands)
- The Blood-Brain Barrier in Health and Disease - Neuroimmunology Congress 2025 (Netherlands)
- The Microbiome-Neuroimmune Connection - Neuroimmunology Congress 2025 (Netherlands)
- Transplantation Immunology - European Immunology 2025 (France)
- Travel & Edible Vaccines - Vaccines-Immunization-2025 (France)
- Vaccine Production & Development - Vaccines-Immunization-2025 (France)
- Vaccines - Vaccines-Immunization-2025 (France)
- Vaccines & Autism - Vaccines-Immunization-2025 (France)
- Vaccines against Drugs - Vaccines-Immunization-2025 (France)
- Vaccines against Infectious Diseases - Vaccines-Immunization-2025 (France)
- Vaccines for Immune Mediated Diseases - Vaccines-Immunization-2025 (France)
- Vaccines for Pregnant Women & Neonates - Vaccines-Immunization-2025 (France)
- Vaccines for Unconventional Diseases - Vaccines-Immunization-2025 (France)
- Vectors, Adjuvants & Delivery Systems - Vaccines-Immunization-2025 (France)
- Viral Immunology - European Immunology 2025 (France)